The Top 5 Best Places to Work in Thailand for 2021 Revealed
BANGKOK, Nov. 25, 2021 /PRNewswire/ -- Novo Nordisk, Zoetis, Roche, PJ Parawood, Inova pharmaceuticals are recognized as the top 5 best places to work in Thailand for 2021 according to the annual prestigious "Best Places to Work" workplace research program. Best Places to Work is an international certification program, considered as the "Platinum Standard" in identifying and recognizing top workplaces around...
Novo Nordisk Indonesia achieves the Best Place To Work certification for 2021
JAKARTA, Indonesia, Nov. 25, 2021 /PRNewswire/ -- Novo Nordisk Indonesia, an affiliate of the global healthcare company with more than 95 years of innovation and leadership in diabetes care, has been recognized as one of the best companies to work in Indonesia for 2021. During the assessment, the company received outstanding scores across several aspects of their workplace, fostering...
Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors
- New investors include US life science investors HealthQuest Capital, Casdin Capital, and American Cancer Society BrightEdge, and Asia-based global healthcare investors Tybourne Capital Management and NSG Ventures - Following the most recent strategic investment of $26 million from Guardant Health, the company has now secured more than $135 million in total...
Biotron Drug Effective Against COVID-19 In Animals
BIT225 administered orally significantly reduced viral load in the lungs and blood of animals challenged with SARS-CoV-2. BIT225 protected against severe disease, indicated by the significant prevention of body weight loss in animals treated with BIT225 compared to non-treated controls. Pro-inflammatory cytokines were also significantly reduced in the lungs and blood of BIT225 treated animals compared...
How CIIE offers a window for multinational companies into the Chinese market
SHANGHAI, Nov. 25, 2021 /PRNewswire/ -- Opening up is the hallmark of contemporary China. The China International Import Expo (CIIE) is poised to shape a link between China and the global market. Scheduled from Nov 5 to 10, the 4th CIIE presented a total of 422 new products, technologies, and services, a...
Henlius Novel Anti PD-L1/TIGIT Bispecific Antibody Received Clinical Trial Approval in Australia
SHANGHAI, Nov. 25, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the filing of a clinical trial for HLX301, a Recombinant Humanized Anti-PDL1 and Anti-TIGIT Bispecific Antibody, in Patients with locally advanced or metastatic solid tumours has been approved by the Bellberry Human Research Ethics Committee ("HREC"), and Clinical Trial Notification ("CTN") has been acknowledged by the...
More cancer patients in Africa to benefit from advanced radiation therapy with Elekta Unity MR-Linac
STOCKHOLM, Nov. 25, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its latest African order for Elekta Unity MR-Linac comes less than six months after the company introduced its ACCESS 2025 strategy, which includes giving more than 300 million people access to radiation therapy with the addition of 800 to 1,000 additional Elekta linacs in underserved markets. In addition to...
Elekta: Interim report, May-October 2021/22
STOCKHOLM, Nov. 25, 2021 /PRNewswire/ -- The increasing need for investments in cancer care and radiotherapy across the globe supported a gradual market recovery during the quarter. Our orders grew with double digits, and despite the continued global supply chain challenges we secured good revenue growth supported by a strong finish of the quarter. Our margins improved sequentially but...
Innovative €250,000 Parenteral Nutrition Research Grant Awarded by Fresenius Kabi
BAD HOMBURG, Germany, Nov. 25, 2021 /PRNewswire/ -- Fresenius Kabi was delighted to announce the winner of their innovative JUMPstart education program and research grant on September 10, 2021. JUMPstart is an initiative that aims to nurture research in the field of parenteral nutrition through the mentoring, education and networking of clinicians...
Sartorius significantly expands activities in South Korea
SHANGHAI, Nov. 25, 2021 /PRNewswire/ -- The life science company Sartorius is investing around 270 million euros, some 300 million U.S. dollars, through the end of 2024 in expanding its activities in South Korea. In the country's biopharma hub Songdo in Incheon, the company plans to launch cell culture media production and to assemble sterile systems for efficient and...
